In CCH-induced VaD, lipocalin-2 (LCN2), a neutrophil gelatinase-associated lipocalin, could activate astrocytes to upregulate vascular endothelial growth factor A (VEGFA), which in turn elevated vascular permeability (Kim et al., 2017). The gene discussed is VEGFA; the disease is columnar cell hyperplasia of the breast.